SLC12A9 and colorectal cancer: Figure 1A–1J illustrates the findings, indicating that SLC12A9 exhibited an increased expression pattern in colorectal cancer across all data sets (TCGA cohort, GSE8671, GSE10972, GSE41657, GSE73360, GSE84984, GSE106582, GSE110224, GSE113513, GSE156355), in comparison to normal tissues (*p < 0.05, **p < 0.01, ***p < 0.001).